Skip to content
PICO Portalanswers from OpenAlex

Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease

PaperCitations, authors & open-access status

Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease have?

PICO Portalcitation count

Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease has 74 citations in the OpenAlex counts PICO Portal stores.

When was Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease published?

PICO Portalyear

Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease has 2007 year in the PICO Portal index.

What is the open-access status of Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease?

PICO Portaloa status

Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease has closed oa status in the PICO Portal index.

What is the DOI of Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease?

PICO Portaldoi

The DOI for Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease is on the source record.

What is the PMID of Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease?

PICO Portalpmid

The PMID for Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease is on the source record.

What is the OpenAlex record for Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease?

PICO Portalopenalex

The OpenAlex for Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial